As anticipated, the GSEA showed that a subset of the p53-target genes was highly significantly enriched (ES = 0.558, p = 0.013 and FDR = 0.007) in the patients with HPV-related HNSCC (Figure 4). This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.